Results 91 to 100 of about 4,291,747 (219)

Neurohumoral Biomarker Profile Associated With Blood Pressure Response After Renal Denervation

The Journal of Clinical Hypertension, Volume 28, Issue 9, September 2026.
ABSTRACT Blood pressure (BP) response after renal denervation (RDN) remains heterogeneous. This study explored whether baseline neurohumoral and inflammation‐related biomarkers were associated with a pronounced ambulatory BP response after RDN. This single‐center post hoc analysis included 40 patients with uncontrolled essential hypertension who ...
Wei Liang, Yingdong Wang, Long Ai, Runmin Sun, Xu Zhao, Heng Yu, Xiaofang Zhang, Caie Li, Jianshu Chen, Ruixin Ma, Qiongying Wang, Xiaowei Zhang, Jing Yu   +12 more
wiley   +1 more source

Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study

Journal of Diabetes Investigation, Volume 17, Issue 9, Page 1524-1532, September 2026.
This real‐world observational study enrolled 256 patients with type 2 diabetes and chronic kidney disease (T2D‐CKD). After 12 months of finerenone treatment, 45 patients completed follow‐up. Finerenone was associated with significant improvements in insulin resistance markers (HOMA‐IR, TyG index), lipid profile (LDL‐C), glycemic control (HbA1c), and ...
Xin Zhao, Bohan Liu, Ran Sun, Yaxuan Shi, Ya Liu   +4 more
wiley   +1 more source

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.

, 2010
The plasma aldosterone concentration:renin ratio (ARR) is widely used for the screening of primary aldosteronism, but its reproducibility is unknown. We, therefore, investigated the within-patient reproducibility of the ARR in a prospective multicenter ...
Letizia C., Mannelli M., Rossi E, Ferri C, Mantero F, Desideri G., Rossi GP, Caridi G, SECCIA RM, RIZZONI, Damiano, Desideri G, Giacchetti G., Mantero F. Primary Aldosteronism in the Prevalence in hYpertension Study Investigators, Seccia T.M., FABRIS, BRUNO, Seccia TM, BERNINI, GIAMPAOLO, Belfiore A., MANTERO F., Ferri C., Letizia C, Patalano A, FERRI, CLAUDIO, Rossi E., Primary Aldosteronism in the Prevalence in hYpertension Study Investigators, Palumbo G, Rossi G.P., Bernini G., Belfiore A, Mallamaci F, Rizzoni D., Patalano A., Caridi G., Mallamaci F., RIZZONI D, Mannelli M, Pessina AC, Fabris B, Palumbo G., Maccario M, Mallamaci, Pessina A.C., DESIDERI, GIOVAMBATTISTA, Bernini G, Maccario M., Giacchetti G   +45 more
core   +1 more source

Is prophylactic nasogastric tube decompression necessary in patients undergoing laparoscopic adrenalectomy for unilateral benign adrenal tumor

Journal of the Formosan Medical Association, 2019
Background/Purpose: This study aims to investigate the safety and feasibility of laparoscopic adrenalectomy for benign adrenal tumor without peri-operative NGT decompression.
Kuan-Ting Chen, Vin-Cent Wu, Kwan-Dun Wu, Kuo-How Huang   +3 more
doaj   +1 more source

Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiators

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2924-2936, August 2026.
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen, Sean Hennessy, Colleen M. Brensinger, Warren B. Bilker, Laura M. Dember, Todd A. Miano, Tat‐Thang Vo, Allison W. Willis, Charles E. Leonard   +8 more
wiley   +1 more source

Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience

Radiology and Oncology, 2020
Adrenal vein sampling (AVS) is essential for diagnostics of primary aldosteronism, distinguishing unilateral from bilateral disease and determining treatment options. We reviewed the performance of AVS for primary aldosteronism at our center during first
Kocjan Tomaz, Jensterle Mojca, Vidmar Gaj, Vrckovnik Rok, Berden Pavel, Stankovic Milenko   +5 more
doaj   +1 more source

Primary aldosteronism: Novel insights

, 2020
Background: Primary aldosteronism is one of the most common causes of secondary hypertension. Patients with this endocrine syndrome are at increased cardiovascular risk, higher than hypertensive individuals with equal blood pressure levels.
Faselis, C., Stavropoulos, K., Imprialos, K., Papademetriou, V., Doumas, M., Tsioufis, K., Dimitriadis, K.   +6 more
core   +1 more source

Clinical significance of parathyroid hormone in mineral and glucose metabolism disorders among patients with primary aldosteronism

SAGE Open Medicine
Objective: To investigate the differences in mineral and glucose metabolic disorders among patients with primary aldosteronism, nonfunctional adrenal tumors, and controls. Methods: A retrospective analysis was conducted on clinical data from 578 patients,
Zhilian Sun, Wenxiu Liu
doaj   +1 more source

Apparent Bilateral Aldosterone Suppression During Adrenal Vein Sampling: An Artefact of the Liaison Chemiluminescence Immunoassay and Other Causes Revealed by Comparisons With Another Commercial Immunoassay and Mass Spectrometry

Clinical Endocrinology, Volume 105, Issue 2, Page 175-184, August 2026.
ABSTRACT Objective Subtyping of primary aldosteronism usually requires adrenal vein sampling (AVS). Interpretation can be compromised by apparent bilateral aldosterone suppression (ABAS), which we hypothesised reflects an artefact of the Liaison immunoassay of aldosterone.
Christina Pamporaki, Carmina T. Fuss, Ralph Kickuth, Lydia Kürzinger, Mirko Peitzsch, Sybille Fuld, Manuel Schulze, Jun Yang, Martin Reincke, Sven Gruber, Felix Beuschlein, Jacques W. M. Lenders, Graeme Eisenhofer   +12 more
wiley   +1 more source

Treatment of Primary Aldosteronism with mTORC1 Inhibitors [PDF]

, 2019
mTORC1 activity is often increased in the adrenal cortex of patients with primary aldosteronism and mTORC1 inhibition decreases aldosterone production in adrenocortical cells, suggesting the mTORC1 pathway as a possible target for treatment of primary ...
Seelig, Eleonora, Kratschmar, Denise V, Donath, Marc Y., Trinh, Beckey, Hall, Michael N, Kratschmar, Denise V., Betz, Matthias J, Meienberg, Fabian, Swierczynska, Marta M., Hall, Michael N., Beuschlein, Felix, Donath, Marc Y, Hepprich, Matthias, Cavelti-Weder, Claudia, Betz, Matthias J., Odermatt, Alex, Beuschlein, Felix; https://orcid.org/, Swierczynska, Marta M, Burkard, Thilo, Reincke, Martin   +19 more
core   +1 more source